Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 41.15 CHF -0.48%
Market Cap: 498.8m CHF
Have any thoughts about
Basilea Pharmaceutica AG?
Write Note

Balance Sheet

Balance Sheet Decomposition
Basilea Pharmaceutica AG

Current Assets 155m
Cash & Short-Term Investments 63m
Receivables 48.9m
Other Current Assets 43.1m
Non-Current Assets 33.7m
PP&E 19.4m
Intangibles 473k
Other Non-Current Assets 13.8m
Current Liabilities 37.8m
Accounts Payable 11.5m
Accrued Liabilities 12m
Other Current Liabilities 14.3m
Non-Current Liabilities 134.1m
Long-Term Debt 95.7m
Other Non-Current Liabilities 38.4m

Balance Sheet
Basilea Pharmaceutica AG

Rotate your device to view
Balance Sheet
Currency: CHF
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
27
27
239
201
173
109
61
54
85
60
Cash
27
27
33
50
37
53
50
54
35
8
Cash Equivalents
0
0
206
151
136
57
11
0
50
52
Short-Term Investments
199
337
0
60
50
20
101
95
0
0
Total Receivables
8
5
7
15
36
30
32
64
62
58
Accounts Receivables
1
2
2
5
4
6
9
0
33
28
Other Receivables
7
3
5
10
32
24
24
0
29
30
Inventory
5
10
15
15
14
19
21
23
24
26
Other Current Assets
5
6
7
2
2
7
8
5
5
8
Total Current Assets
245
385
268
293
275
185
224
241
175
152
PP&E Net
12
11
9
8
6
5
5
3
22
21
PP&E Gross
12
11
9
8
6
5
5
3
22
21
Accumulated Depreciation
34
35
36
37
39
39
24
15
10
11
Intangible Assets
0
0
0
0
0
0
1
1
1
1
Note Receivable
0
0
0
0
0
0
0
2
1
0
Long-Term Investments
0
0
50
50
0
30
0
0
0
0
Other Long-Term Assets
0
3
0
0
0
1
0
0
22
0
Total Assets
257
N/A
399
+55%
328
-18%
351
+7%
282
-20%
221
-21%
230
+4%
247
+8%
221
-11%
173
-22%
Liabilities
Accounts Payable
2
1
2
4
6
7
13
11
0
6
Accrued Liabilities
13
15
15
20
27
29
29
33
28
18
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
124
37
15
Other Current Liabilities
47
53
56
56
34
39
8
7
9
9
Total Current Liabilities
62
69
73
79
67
75
50
174
75
48
Long-Term Debt
0
195
195
196
197
198
240
95
131
95
Other Liabilities
138
120
94
117
85
41
42
37
35
40
Total Liabilities
199
N/A
384
+92%
363
-6%
393
+8%
348
-11%
314
-10%
332
+6%
306
-8%
242
-21%
183
-24%
Equity
Common Stock
11
11
12
12
12
12
12
13
13
13
Retained Earnings
61
22
21
33
55
74
34
1 023
1 011
1 001
Additional Paid In Capital
0
0
0
0
0
0
0
1 030
1 037
1 042
Treasury Stock
0
0
1
1
7
6
53
57
56
54
Other Equity
14
18
25
19
16
25
27
22
4
10
Total Equity
58
N/A
15
-74%
35
N/A
41
-18%
67
-61%
93
-39%
102
-10%
59
+43%
21
+65%
10
+52%
Total Liabilities & Equity
257
N/A
399
+55%
328
-18%
351
+7%
282
-20%
221
-21%
230
+4%
247
+8%
221
-11%
173
-22%
Shares Outstanding
Common Shares Outstanding
11
11
11
11
11
11
11
12
12
12

See Also

Discover More